S Stasik, M Kramer, S Zukunft, C Röllig… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
FLT3-ITD mutations are common druggable alterations in patients with acute myeloid
leukemia (AML) and associated with poor prognosis. Beside typical ITD mutations, point …